BR9810996A - Composição farmacêutica - Google Patents

Composição farmacêutica

Info

Publication number
BR9810996A
BR9810996A BR9810996-0A BR9810996A BR9810996A BR 9810996 A BR9810996 A BR 9810996A BR 9810996 A BR9810996 A BR 9810996A BR 9810996 A BR9810996 A BR 9810996A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
ssri
blocker
relates
present
Prior art date
Application number
BR9810996-0A
Other languages
English (en)
Inventor
Paul John Cummings
Ian Frederic Tulloch
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9810996A publication Critical patent/BR9810996A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA" A presente invenção refere-se a uma composição farmacêutica que compreende um SSRI em forma de liberação rápida e um ß-bloqueador na forma de liberação sustentada.
BR9810996-0A 1997-07-11 1998-07-07 Composição farmacêutica BR9810996A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition
PCT/EP1998/004971 WO1999002142A2 (en) 1997-07-11 1998-07-07 Novel composition comprising an ssri and a beta-blocker

Publications (1)

Publication Number Publication Date
BR9810996A true BR9810996A (pt) 2000-08-08

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810996-0A BR9810996A (pt) 1997-07-11 1998-07-07 Composição farmacêutica

Country Status (26)

Country Link
EP (1) EP0996466A2 (pt)
JP (1) JP2002508003A (pt)
KR (1) KR20010021644A (pt)
CN (1) CN1262627A (pt)
AP (1) AP2000001728A0 (pt)
AR (1) AR016128A1 (pt)
AU (1) AU9340198A (pt)
BG (1) BG104119A (pt)
BR (1) BR9810996A (pt)
CA (1) CA2295822A1 (pt)
CO (1) CO4950552A1 (pt)
DZ (1) DZ2556A1 (pt)
EA (1) EA200000112A1 (pt)
GB (1) GB9714675D0 (pt)
HU (1) HUP0003074A3 (pt)
ID (1) ID24191A (pt)
IL (1) IL133869A0 (pt)
MA (1) MA24604A1 (pt)
NO (1) NO20000107L (pt)
OA (1) OA11276A (pt)
PE (1) PE99699A1 (pt)
PL (1) PL338017A1 (pt)
SK (1) SK72000A3 (pt)
TR (1) TR200000074T2 (pt)
WO (1) WO1999002142A2 (pt)
ZA (1) ZA986138B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7417038B1 (en) 1998-10-15 2008-08-26 Imperial Innovations Limited Methods of treating cachexia
PL205109B1 (pl) 1998-11-02 2010-03-31 Elan Pharma Int Ltd Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
ATE526950T1 (de) 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
EP2263658A1 (en) 2000-10-30 2010-12-22 Euro-Celtique S.A. Controlled release hydrocodone formulations
EP1793818A2 (en) * 2004-09-17 2007-06-13 Neurocure Ltd. Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
CN100469356C (zh) * 2006-09-08 2009-03-18 山东益康药业有限公司 复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
ES2145977T3 (es) * 1995-08-16 2000-07-16 Lilly Co Eli Potenciacion de la respuesta de la serotonina.
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
CN1262627A (zh) 2000-08-09
BG104119A (en) 2000-12-29
HUP0003074A2 (hu) 2001-01-29
WO1999002142A2 (en) 1999-01-21
KR20010021644A (ko) 2001-03-15
NO20000107D0 (no) 2000-01-10
AP2000001728A0 (en) 2000-03-31
AU9340198A (en) 1999-02-08
WO1999002142A3 (en) 1999-04-15
PE99699A1 (es) 1999-12-21
HUP0003074A3 (en) 2001-12-28
OA11276A (en) 2003-07-31
JP2002508003A (ja) 2002-03-12
NO20000107L (no) 2000-01-10
PL338017A1 (en) 2000-09-25
EP0996466A2 (en) 2000-05-03
EA200000112A1 (ru) 2000-10-30
CA2295822A1 (en) 1999-01-21
SK72000A3 (en) 2000-12-11
CO4950552A1 (es) 2000-09-01
ID24191A (id) 2000-07-13
ZA986138B (en) 2000-01-10
GB9714675D0 (en) 1997-09-17
MA24604A1 (fr) 1999-04-01
AR016128A1 (es) 2001-06-20
IL133869A0 (en) 2001-04-30
TR200000074T2 (tr) 2000-05-22
DZ2556A1 (fr) 2003-02-15

Similar Documents

Publication Publication Date Title
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
BR0104654A (pt) Artigo absorvente
BR9808466A (pt) Método para distribuição oral de proteìnas
BR9804802A (pt) Composi-Æo de libera-Æo sustentada de drogas encapsuladas em micropoarticulas de cido hialuronico
PT952829E (pt) Composicao farmaceutica de fenofibrato que apresenta uma biodisponibilidade elevada e seu modo de preparacao
BG103657A (en) New modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminebenzene and methods for their prepration
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
BR9502555A (pt) Composiçao que consiste de um dendrímero e de uma substancia ativa ocluida no dendrímero processo para a preparaçao de uma tal composiçao e processo para liberaçao de uma substancia ativa
FR2733427B1 (fr) Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique
BR9915846A (pt) Artigo absorvente com costuras religáveis não irritantes
BR9809819A (pt) Compostos e métodos para a inibição da expressão de vcam-1
BR9808948A (pt) Composição de confeitaria
HU9601161D0 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
HUP0100938A2 (hu) Felületaktív rendszer keveréket tartalmazó mosószerkészítmény és alkalmazása
BR9808875A (pt) Combinação de analgésicos
BR0211336A (pt) Métodos para o tratamento da fibrose do fìgado
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
BR9810996A (pt) Composição farmacêutica
ITRM970254A0 (it) Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato
EE200000742A (et) Karnitiini ning inositoolfosfaati sisaldav kompositsioon toidulisandi või ravimina
DE69428788D1 (de) Parfumzusammensetzung
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]